# Eli Lilly Study Finds Weight Reductions in Adolescents With Zepbound

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/57935
Published: 2026-11-15T23:52:35.000Z
Updated: 2026-11-15T23:52:35.000Z
Section: Business

> Participants had obesity or excess weight and related health conditions.

A study of Eli Lilly’s Zepbound found weight reductions among adolescent participants.

Participants were adolescents with obesity or excess weight who had related health conditions.

The study examined Zepbound, also known as tirzepatide.


